We are investigating a data breach that led to unauthorized access to the sensitive information of patients affiliated with DermCare Management (“DermCare”), a Florida-based full-service practice management company for more than 70 skincare and dermatology clinics in Florida, Texas, Virginia, and California.

We are advising Vistagen Therapeutics, Inc. (NASDAQ: VTGN) investors that the firm is investigating potential legal claims arising from alleged false statements about Vistagen’s drug candidate fasedienol. Current shareholders are encouraged to contact the firm.

We are investigating a data breach that led to unauthorized access to the sensitive information of 337,917 individuals affiliated with Cookeville Regional Medical Center (“CRMC”), a Tennessee-based hospital with 289 beds.

We are investigating a data breach that led to unauthorized access to the sensitive information of 285,000 individuals affiliated with North Texas Behavioral Health Authority (“NTBHA”), a Texas based provider of mental health and substance use treatment and services.

We are investigating a data breach that led to unauthorized access to the sensitive information of 47,876 individuals affiliated with Ameriprise Financial, Inc. (“Ameriprise”), a Minnesota-based regional brokerage firm.

We are investigating a data breach that led to unauthorized access to the sensitive information of 160,000 individuals affiliated with Southern Illinois Dermatology, an Illinois-based skincare provider.